BMC Cardiovascular Disorders· 2026Q2
Efficacy and safety of Shenfu injection on sepsis-induced myocardial dysfunction: a meta-analysis and trial sequential analysis
- 0citations
- Q2SCImago
- 2026year
Short summary
Adjunctive Shenfu Injection (SFI) in 10 RCTs (n=691) improved cardiac function markers (lower NT-proBNP and cTnI, higher LVEF) and reduced SIMD incidence (OR=0.44) but did not impact 28-day mortality or hospital stay.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openPharmacologyPharmacology, Toxicology and Pharmaceutics